Cold Plasma Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030
Cold Plasma Market Share, Size, Trends, Industry Analysis Report, 2022 - 2030

Cold Plasma Market Share, Size, Trends, Industry Analysis Report, By Application (Surface Treatment, Sterilization & Disinfection, Coating, Finishing, Adhesion, Wound Healing, Others); By End-Use; By Regime; By Region; Segment Forecast, 2022 - 2030

  • Published Date:Feb-2022
  • Pages: 112
  • Format: PDF
  • Report ID: PM2308
  • Base Year: 2021
  • Historical Data: 2018 - 2020

Report Outlook

The global cold plasma market was valued at USD 1.67 billion in 2021 and is expected to grow at a CAGR of 14.9% during the forecast period. A wide range of industries such as textile, food, medical, and printing, among others, are using this technology, which is the factor that is driving the market growth during the forecast period. They have a wide range of uses in different industries.

Cold Plasma Market SizeKnow more about this reportrequest for sample pages

The need for the industry is developing globally due to its increasing applications in various sectors such as printing, adhesion, coating, and others. Furthermore, certain cold plasma features, such as better wettability, lower chemical consumption, and lower water use, are assisting in expanding the cold plasma market.

Product consumption is being driven by decontamination in various food goods like vegetables, fruits, and meats. Its capacity to destroy germs while not affecting the physicochemical properties of food is boosting its popularity. The United States Department of Agriculture (USDA) has recommended a new treatment known as 'purple blow torches,' which can destroy 99.9% of viruses.

These elements are predicted to drive the cold plasma industry. Medical research for its usage in lung, bladder, skin, and breast cancer treatment has provided it with numerous potentials. Its utilization in packaging and clinical uses is likely to enhance the cold plasma market during the forecast period. Further, the chemical removes surface hairiness in the textile sector, desires cotton fabrics, and offers to shrink resistance to woolen materials. It is utilized for microbial-free material packaging and is used in meat and poultry packaging.

The procedure uses less water, which lowers the cost of wastewater treatment. Also, food decontamination and spoilage reduction are significant challenges that must be handled during agricultural production, processing, and packing to ensure food safety and durability. Furthermore, this technique has given a new direction to the concept of food purification under ambient conditions, which will boost the cold plasma market over the forecast period.

However, the high capital investment for cold plasma technology is restraining the market growth. Companies generally evaluate the benefits of technology about their investment and the time required to recover that cost while keeping their budget in mind. Cold plasma coating methods are capital-intensive because the equipment utilized in these spraying technologies, such as vacuum equipment, is expensive and requires unique working conditions, such as relatively low temperature and regulated vacuum conditions.

Cold Plasma MarketKnow more about this reportrequest for sample pages

Industry Dynamics

Growth Drivers
Cold plasma has numerous advantages, including low water and energy consumption, little fiber damage, reduced flammability, low chemical utilization, enhanced wettability, low cost, and worker friendliness. In addition, in November 2021, the NOVOPLASM collaboration has declared that it is the "first in the world" to create this technology to treat infectious burns and skin transplant wound healing. Thus, this technology announcement by major players is driving the market growth.

Further, the increasing number of COVID patients coupled with such therapy has demonstrated promising results for its treatment. Cold plasma therapy is also promoted to a viable treatment for the continuing COVID-19 outbreak. This type of therapy is becoming more popular due to its potential utility in coronavirus treatment. The U.S., China, Turkey, Spain, and the United Kingdom are just a few countries exploring this type of treatment to help address the global COVID-19 epidemic.

Even in India, it was discovered that a hospital in Delhi successfully healed a COVID-19 patient utilizing plasma therapy. The patients were discovered to have a higher respiratory rate and oxygen saturation level. Moreover, According to the Canadian Cancer Society, an estimated 27,400 women will be diagnosed with breast cancer by 2021. By 2021, this will account for 25% of all new cancer cases in women, with 5,100 women dying from breast cancer.

Cold plasma also increases wound sterilizing, blood coagulation, and cell proliferation during wound healing when used in conjunction with chemotherapy. Its application enables the successful medical treatment of cancer and other skin injuries and disorders. It was also discovered that cold plasma was recently employed in Germany in restricted early trials as palliative therapy for head and neck cancer patients. As a result, the growing uses of cold plasma in wound healing, cancer treatment, and infectious disorders are boosting the market's growth.

Report Segmentation

The market is primarily segmented based on end-use, regime, application, and region.

By End-Use

By Regime

By Application

By Region

  • Automotive
  • Electronics & Semiconductors
  • Food Processing & Packaging
  • Medical
  • Aerospace
  • Polymers & Plastics
  • Others
  • Low Pressure
  • Atmospheric Pressure
  • Surface Treatment
  • Sterilization & Disinfection
  • Coating
  • Finishing
  • Adhesion
  • Wound Healing
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this reportrequest for sample pages

Insight by Regime

Based on the regime segment, the atmospheric pressure segment is anticipated to be the largest revenue shareholder in 2021. Because of its use in various industries such as medicine, food, textiles, and packaging, atmospheric has a larger market share. The low-pressure type has a moderate share of the semiconductor manufacturing market. Semiconductors have grown in popularity due to their use in the electrical and electronic industries, which has increased product consumption.

Geographic Overview

Europe had the largest revenue share in 2021. The presence of a high number of cold plasma manufacturers and expanding R&D efforts in Germany can be linked to Europe's large global industry share. Followed by Europe, North America leads the market. This is due to the increasing use of technologically improved products, which will drive the region's cold plasma market expansion over the forecast period. George Washington University (GW) has signed a new USD 3.2 million company trade agreement with US Patent Innovations to assist in the development of flexible devices for cancer therapies.

Moreover, Asia Pacific is expected to witness a high CAGR in the global market in 2021. The region is growing due to the rising demand for cold plasma technology in China, India, Japan, and South Korea, among other countries. Despite this fact, most multinational corporations are concentrating their efforts in this region on establishing and extending their R&D skills and distribution networks.

Competitive Insight

Some of the major players operating in the global market include AcXys Plasma Technologies, Adtec Plasma Technology Co., Ltd., Apyx Medical, Coating Plasma Innovation, Enercon Industries Corporation, Europlasma N.V., Henniker Plasma, Neoplas GmbH, Nordson Corporation, P2i Limited, Plasmatreat GmbH, Softal Corona & Plasma Gmbh, Surfx Technologies, LLC, Tantec A/S, and Thierry Corporation, among others.

Cold Plasma Market Report Scope

Report Attributes


Market size value in 2021

USD 1.67 billion

Revenue forecast in 2030

USD 5.44 billion


14.9% from 2022 - 2030

Base year


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2022 to 2030

Segments covered

By End-Use, By Regime, By Application, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Key companies

AcXys Plasma Technologies, Adtec Plasma Technology Co., Ltd., Apyx Medical, Coating Plasma Innovation, Enercon Industries Corporation, Europlasma N.V., Henniker Plasma, Neoplas GmbH, Nordson Corporation, P2i Limited, Plasmatreat GmbH, Softal Corona & Plasma Gmbh, Surfx Technologies, LLC, Tantec A/S, and Thierry Corporation.